Azenta Inc (AZTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
Nov 13,2023: Azenta Announces Agreement Between B Medical and The Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo for a Significant National Universal Health Project
Nov 08,2023: Azenta Announces Fiscal 2023 Fourth Quarter and Full Year Earnings Conference Call and Webcast
Oct 19,2023: Azenta to Host GENEWIZ Week November 6-10, 2023
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Azenta Inc (Azenta), formerly Brooks Automation Inc, provides sample exploration and management solutions for the life sciences market. The company’s product portfolio includes automated cold storage systems, cryogenic storage systems, consumables, and instruments such as racks, tubes, cups, plates, and foils. Azenta also offers informatics for planning, data management, virtualization, visualization, scheduling laboratory workflow, sampling inventory and logistics, monitoring environment and temperature, and management of clinical trial and consent. The company’s service offerings include component exchange, spare parts, repair and upgrades. It has operations in Europe, Asia-Pacific, and North America. Azenta is headquartered in Burlington, Massachusetts, the US.Azenta Inc Key Recent Developments
Nov 13,2023: Azenta Reports Fourth Quarter and Full Year Fiscal 2023 Results, Ended September 30, 2023Nov 13,2023: Azenta Announces Agreement Between B Medical and The Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo for a Significant National Universal Health Project
Nov 08,2023: Azenta Announces Fiscal 2023 Fourth Quarter and Full Year Earnings Conference Call and Webcast
Oct 19,2023: Azenta to Host GENEWIZ Week November 6-10, 2023
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Thermo Fisher Scientific Inc
- Genscript Biotech Corp
- Liconic AG
- Integrated DNA Technologies Inc
- Hamilton Company
- Haier Biomedical HK Co., Limited
- Laboratory Corp of America Holdings
- Novogene Co Ltd
- Eurofins Scientific SE
- BGI Genomics Co Ltd
- Rorze Corp
- Hirata Corp
- Vestfrost A/S
- Twist Bioscience Corp